Amylin is a peptide co-secreted with insulin in response to food intake. It controls gastric emptying, inhibits glucagon secretion, and promotes satiety. Several amylin receptor agonists are in ...
In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...
The Hearty Soul on MSN
New Research Uncovers Unexpected Health Gains From GLP‑1 Medications
Heart failure with preserved ejection fraction, or HFpEF, is now the most common form of heart failure. Many people who ...
Investor's Business Daily on MSN
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions. Is the party over?
Using different oximeter devices for monitoring stable patients under NIV or CPAP may have an unpredictable effect on results and clinical decisions.
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...
The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...
GLP-1 Drugs Help Protect Against Sleep Apnea, Study Says By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 21, 2025 (HealthDay News) — Weight-loss drugs like Ozempic and Zepbound might help protect ...
For the first time, researchers have shown that tackling obstructive sleep apnea’s two root causes at once, using both oxygen and a jaw-forwarding device, can dramatically cut breathing interruptions ...
TUESDAY, Oct. 21, 2025 (HealthDay News) — Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients ...
Rochester, Minn.-based Mayo Clinic has developed an AI algorithm that can detect obstructive sleep apnea using electrocardiogram results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback